PD-L1 immunohistochemistry in gastric cancer: Comparison of combined positive score and tumor area positivity across 28-8, 22C3, and SP263 assays

被引：0

作者：

Klempner, Samuel J.

Cowden, Eric S.

Cytryn, Samuel Louis

Fassan, Matteo

Kawakami, Hisato

Shimada, Hideaki

Tang, Laura H.

Wagner, Daniel-Christoph

Yatabe, Yasushi

Savchenko, Alexander

Salcius, Jennifer

Johng, Dorhyun

Fairchild, Lauren

Chen, Jing

Montenegro, Giuliana

Moehler, Markus H.

机构：

[1] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA USA

[2] Novartis Pharmaceut, Cambridge, MA USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY USA

[4] Univ Padua, Dept Med DIMED, Padua, Italy

[5] Veneto Inst Oncol IOV IRCCS, Padua, Italy

[6] Kindai Univ, Dept Med Oncol, Fac Med, Osaka, Japan

[7] Toho Univ, Dept Surg & Clin Oncol, Grad Sch Med, Tokyo, Japan

[8] Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, New York, NY USA

[9] Univ Med Ctr Mainz, Inst Pathol, Mainz, Germany

[10] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Univ Clin Mainz, Mainz, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2625

引用

页数：1